Article

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer

2024-03-13

Abstract excerpt

Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the latter known for its aggressiveness. We employed integrative transcriptome and metabolome analyses to identify potential genes contributing to the molecular subtype differentiation and its metabolic features. Transcriptome analysis in PDAC patient cohorts revea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c1a49394-2e20-551f-b6c1-8b547fb7d94c
DOI: 10.1101/2024.03.12.584316

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerDOI 10.1101/2024.03.12.584316Read

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancerSemantic proximity Read

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancerSemantic proximity Read

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma ClassificationSemantic proximity Read

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancerSemantic proximity Read

SERPINB3 induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancerSemantic proximity Read

Multidimensional analyses identify genes of high priority for pancreatic cancer researchSemantic proximity Read

Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)Semantic proximity Read

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinomaSemantic proximity Read

Subtype specific metabolic vulnerabilities in pancreatic cancerSemantic proximity Read

Functional metabolic phenotyping of human pancreatic ductal adenocarcinomaSemantic proximity Read

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modelingSemantic proximity Read

LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolismSemantic proximity Read